These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2142930)

  • 1. Relative bioavailability of ethinyl estradiol from two different oral contraceptive formulations after single oral administration to 18 women in an intraindividual cross-over design.
    Kuhnz W; Hümpel M; Schütt B; Louton T; Steinberg B; Gansau C
    Horm Res; 1990; 33(1):40-4. PubMed ID: 2142930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of ethinyl estradiol in the serum of 31 young women following a treatment period of 3 months with two low-dose oral contraceptives in an intraindividual cross-over design.
    Kuhnz W; Back D; Power J; Schütt B; Louton T
    Horm Res; 1991; 36(1-2):63-9. PubMed ID: 1839986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
    Kuhnz W; Schütt B; Power J; Back DJ
    Arzneimittelforschung; 1992 Sep; 42(9):1139-41. PubMed ID: 1445482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of ethynylestradiol in the presence and absence of gestodene and desogestrel.
    Orme M; Back DJ; Ward S; Green S
    Contraception; 1991 Apr; 43(4):305-16. PubMed ID: 1830266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of gestodene/ethinyl estradiol (Femovan) or a combination of desogestrel/ethinyl estradiol (Marvelon) and single-dose ethinyl estradiol bioequivalence from both oral contraceptives.
    Hümpel M; Täuber U; Kuhnz W; Pfeffer M; Brill K; Heithecker R; Louton T; Steinberg B; Seifert W; Schütt B
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):329-33. PubMed ID: 2142574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of the contraceptive steroids gestodene, 3-keto-desogestrel and ethinylestradiol in human serum.
    Kuhnz W; Pfeffer M; al-Yacoub G
    J Steroid Biochem; 1990 Feb; 35(2):313-8. PubMed ID: 2308344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum ethinyl estradiol, sex-hormone-binding globulin, corticoid-binding globulin and cortisol levels in women using two low-dose combined oral contraceptives.
    Hümpel M; Tüber U; Kuhnz W; Pfeffer M; Brill K; Heithecker R; Louton T; Steinberg B
    Horm Res; 1990; 33(1):35-9. PubMed ID: 2142929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestodene and desogestrel do not have a different influence on concentration profiles of ethinylestradiol in women taking oral contraceptives--results of isotope dilution mass spectrometry measurements.
    Siekmann L; Siekmann A; Bidlingmaier F; Brill K; Albring M
    Eur J Endocrinol; 1998 Aug; 139(2):167-77. PubMed ID: 9724072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
    Jung-Hoffman C; Kuhl H
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 2):2183-97. PubMed ID: 2147819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C; Fitzner M; Kuhl H
    Horm Res; 1991; 36(5-6):238-46. PubMed ID: 1823082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-dose and 3-month clinical-pharmacokinetic study with a new combination oral contraceptive.
    Heuner A; Kuhnz W; Heger-Mahn D; Richert K; Hümpel M
    Adv Contracept; 1995 Sep; 11(3):207-25. PubMed ID: 8533624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive.
    Täuber U; Kuhnz W; Hümpel M
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 2):1414-20. PubMed ID: 2220966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
    Bonnar J; Daly L; Carroll E
    Int J Fertil; 1987; 32 Suppl():21-8. PubMed ID: 2906344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical comparison of monophasic oral contraceptive preparations of gestodene/ethinyl estradiol and desogestrel/ethinyl estradiol. Latin American Oral Contraceptive Study Group.
    Contraception; 1994 Sep; 50(3):201-14. PubMed ID: 7805371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of felbamate on the pharmacokinetics of a low-dose combination oral contraceptive.
    Saano V; Glue P; Banfield CR; Reidenberg P; Colucci RD; Meehan JW; Haring P; Radwanski E; Nomeir A; Lin CC
    Clin Pharmacol Ther; 1995 Nov; 58(5):523-31. PubMed ID: 7586946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum resistin levels in women taking combined oral contraceptives containing desogestrel or gestodene.
    Rechberger T; Tomaszewski J; Pieprzowska-Białek A; Kulik-Rechberger B; Skorupski P
    Contraception; 2004 Jun; 69(6):477-80. PubMed ID: 15157792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.
    Baisini O; Benini F; Petraglia F; Kuhnz W; Scalia S; Marschall HU; Brunetti G; Tauschel HD; Lanzini A
    Eur J Clin Pharmacol; 2004 Sep; 60(7):481-7. PubMed ID: 15289960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desogestrel, norgestimate, and gestodene: the newer progestins.
    Kaplan B
    Ann Pharmacother; 1995; 29(7-8):736-42. PubMed ID: 8520092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
    N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.